BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 10898220)

  • 1. Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair.
    Scheid A; Wenger RH; Christina H; Camenisch I; Ferenc A; Stauffer UG; Gassmann M; Meuli M
    Pediatr Surg Int; 2000; 16(4):232-6. PubMed ID: 10898220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3.
    Scheid A; Wenger RH; Schäffer L; Camenisch I; Distler O; Ferenc A; Cristina H; Ryan HE; Johnson RS; Wagner KF; Stauffer UG; Bauer C; Gassmann M; Meuli M
    FASEB J; 2002 Mar; 16(3):411-3. PubMed ID: 11790723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport.
    Ozawa K; Kondo T; Hori O; Kitao Y; Stern DM; Eisenmenger W; Ogawa S; Ohshima T
    J Clin Invest; 2001 Jul; 108(1):41-50. PubMed ID: 11435456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing.
    Elson DA; Ryan HE; Snow JW; Johnson R; Arbeit JM
    Cancer Res; 2000 Nov; 60(21):6189-95. PubMed ID: 11085544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
    Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
    Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the fetal fibroblast and transforming growth factor-beta in a model of human fetal wound repair.
    Lin RY; Adzick NS
    Semin Pediatr Surg; 1996 Aug; 5(3):165-74. PubMed ID: 8858763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.
    Ozaki H; Yu AY; Della N; Ozaki K; Luna JD; Yamada H; Hackett SF; Okamoto N; Zack DJ; Semenza GL; Campochiaro PA
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):182-9. PubMed ID: 9888442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
    Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
    Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.
    Colwell AS; Beanes SR; Soo C; Dang C; Ting K; Longaker MT; Atkinson JB; Lorenz HP
    Plast Reconstr Surg; 2005 Jan; 115(1):204-12. PubMed ID: 15622252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ; Bellamy WT; Briehl MM; Powis G
    Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
    Lee SH; Wolf PL; Escudero R; Deutsch R; Jamieson SW; Thistlethwaite PA
    N Engl J Med; 2000 Mar; 342(9):626-33. PubMed ID: 10699162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in Wilms' tumor.
    Karth J; Ferrer FA; Perlman E; Hanrahan C; Simons JW; Gearhart JP; Rodriguez R
    J Pediatr Surg; 2000 Dec; 35(12):1749-53. PubMed ID: 11101729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
    Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
    Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death.
    Kotch LE; Iyer NV; Laughner E; Semenza GL
    Dev Biol; 1999 May; 209(2):254-67. PubMed ID: 10328919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells.
    Kim HH; Lee SE; Chung WJ; Choi Y; Kwack K; Kim SW; Kim MS; Park H; Lee ZH
    Cytokine; 2002 Jan; 17(1):14-27. PubMed ID: 11886167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.
    Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C
    Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia.
    Salceda S; Beck I; Caro J
    Arch Biochem Biophys; 1996 Oct; 334(2):389-94. PubMed ID: 8900415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
    Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
    Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
    Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
    Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.